170 filings
8-K
HGENQ
Humanigen, Inc
8 Jan 24
Entry into a Material Definitive Agreement
5:02pm
8-K
HGENQ
Humanigen, Inc
14 Sep 23
Departure of Directors or Certain Officers
4:01pm
8-K
HGENQ
Humanigen, Inc
24 Jul 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9:25pm
8-K
HGENQ
Humanigen, Inc
19 Apr 23
Other Events
6:00am
8-K
HGENQ
Humanigen, Inc
6 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:45pm
8-K
52jr1e08t
13 Mar 23
Regulation FD Disclosure
6:00am
8-K
0tl86 r6xti5
2 Mar 23
Other Events
5:15pm
8-K
acnd2d vijnhj
24 Feb 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:48pm
8-K
tsp4 4jn9rjfqv45t
22 Dec 22
Entry into a Material Definitive Agreement
5:20pm
8-K
dr2oqnq9dtohp
14 Nov 22
Humanigen Reports Third Quarter 2022 Financial Results
4:16pm
8-K
a9gasep5
6 Oct 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:13pm
8-K
8prdk1bl3b1dysk2
29 Sep 22
Departure of Directors or Certain Officers
5:15pm
8-K
hujeqib bod
2 Sep 22
Departure of Directors or Certain Officers
4:07pm
8-K
7ty9lq iyh
26 Aug 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
bpihal d7a
12 Aug 22
Humanigen Reports Second Quarter 2022 Financial Results
4:07pm
8-K
gc289oc2
26 Jul 22
Humanigen Implements Strategic Realignment of Pipeline and Resources to Achieve Key Clinical Milestones
4:05pm
8-K
13j 1e9ue
13 Jul 22
Humanigen receives preliminary topline data from NIH/NIAID study of lenzilumab in ACTIV-5/BET-B
6:01am
8-K
raeits5u7 xw4xjpxu
30 Jun 22
Other Events
8:24am
8-K
1mtikk2u
10 Jun 22
Submission of Matters to a Vote of Security Holders
4:56pm
8-K
zd1vzctxtrih34g0
5 May 22
Humanigen Reports First Quarter 2022 Financial Results
4:05pm